Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.3 is now shown on the study page, indicating a newer version of the page content. This appears to be an administrative update rather than a substantive change to the study information.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a metadata/QA update with no visible changes to trial details.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page footer now displays Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing v3.4.0. This appears to be a minor administrative update with no impact on the study information presented.SummaryDifference0.1%

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.